南模生物：2025年前三季度净利润约2676万元

Group 1 - Company Nanmo Bio reported a revenue of approximately 303 million yuan for the first three quarters of 2025, representing a year-on-year increase of 14.29% [1] - The net profit attributable to shareholders of the listed company was approximately 26.76 million yuan, with a basic earnings per share of 0.34 yuan [1] - As of the report date, the market capitalization of Nanmo Bio was 3.6 billion yuan [2] Group 2 - The A-share market has surpassed 4000 points, marking a significant resurgence after a decade of stagnation, with technology leading the market's transformation [2] - A new "slow bull" market pattern is emerging, indicating a shift in market dynamics [2]